J A Otter1, G L French. 1. Centre for Clinical Infection and Diagnostic Research (CIDR), Department of Infections Diseases, King's College London School of Medicine, London, UK. jonathan.otter@kcl.ac.uk
Abstract
BACKGROUND: New distinct strains of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA) have emerged as a cause of infection in previously healthy individuals in community settings. It is important to identify CA-MRSA for clinical management, epidemiological analysis, infection prevention and control, and regulatory reporting, but definitions and nomenclature of these strains are confused. AIM: To review attempts to define CA-MRSA and propose a new definition. METHODS: Non-systematic review. FINDINGS: Epidemiological definitions were useful for differentiating CA-MRSA and healthcare-associated (HA)-MRSA strain types in the past. However, although HA-MRSA strain types are rarely transmitted in the community, CA-MRSA strains have started to be transmitted in healthcare facilities, so epidemiological definitions are breaking down. CA-MRSA are community strains of S. aureus that have acquired the meticillin resistance gene, mecA. They are distinct from HA-MRSA and should be defined genetically. This may be done by combining genotypic typing by multi-locus sequence or spa with analysis of the staphylococcal cassette chromosome mec. Carriage of Panton-Valentine leukocidin or antimicrobial susceptibility profiles can be useful indicators of CA-MRSA but should not be used for their definition. CONCLUSION: For full assessment of their epidemiology, MRSA infections should be characterized as: (1) caused by HA- or CA-MRSA strain types; (2) acquired in community or healthcare settings; and (3) onset in the community or healthcare facility.
BACKGROUND: New distinct strains of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA) have emerged as a cause of infection in previously healthy individuals in community settings. It is important to identify CA-MRSA for clinical management, epidemiological analysis, infection prevention and control, and regulatory reporting, but definitions and nomenclature of these strains are confused. AIM: To review attempts to define CA-MRSA and propose a new definition. METHODS: Non-systematic review. FINDINGS: Epidemiological definitions were useful for differentiating CA-MRSA and healthcare-associated (HA)-MRSA strain types in the past. However, although HA-MRSA strain types are rarely transmitted in the community, CA-MRSA strains have started to be transmitted in healthcare facilities, so epidemiological definitions are breaking down. CA-MRSA are community strains of S. aureus that have acquired the meticillin resistance gene, mecA. They are distinct from HA-MRSA and should be defined genetically. This may be done by combining genotypic typing by multi-locus sequence or spa with analysis of the staphylococcal cassette chromosome mec. Carriage of Panton-Valentine leukocidin or antimicrobial susceptibility profiles can be useful indicators of CA-MRSA but should not be used for their definition. CONCLUSION: For full assessment of their epidemiology, MRSA infections should be characterized as: (1) caused by HA- or CA-MRSA strain types; (2) acquired in community or healthcare settings; and (3) onset in the community or healthcare facility.
Authors: James Q Del Rosso; Ted Rosen; Diane Thiboutot; Guy F Webster; Richard L Gallo; James J Leyden; Clay Walker; George Zhanel; Lawrence Eichenfield Journal: J Clin Aesthet Dermatol Date: 2016-06-01
Authors: A C Fluit; M D Jansen; T Bosch; W T M Jansen; L Schouls; M J Jonker; C H E Boel Journal: Antimicrob Agents Chemother Date: 2016-11-21 Impact factor: 5.191
Authors: Ziad W Jaradat; Qutaiba O Ababneh; Sherin T Sha'aban; Ayesha A Alkofahi; Duaa Assaleh; Anan Al Shara Journal: Pathog Glob Health Date: 2020-10-28 Impact factor: 2.894
Authors: L Hu; Y Li; Y Lu; J D Klena; Y Qiu; Y Lin; M Jiang; X Shi; L Chen; X Liu; H Ma; J Cheng; S Wu; B Kan; Q Hu Journal: Epidemiol Infect Date: 2016-07-22 Impact factor: 4.434
Authors: S Bruzzese; K Bush; J Leal; J Kim; D M Vickers; A Rusk; S Fathima; V Li; L Chui; M Louie; E Henderson Journal: Epidemiol Infect Date: 2016-03-07 Impact factor: 4.434
Authors: U Dermota; I Zdovc; I Strumbelj; I Grmek-Kosnik; H Ribic; M Rupnik; M Golob; U Zajc; M Bes; F Laurent; M Mueller-Premru Journal: Epidemiol Infect Date: 2014-07-18 Impact factor: 4.434